We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CNH:NYSECNH Industrial N.V. Analysis

Data as of 2026-05-25 - not real-time

$10.11

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

CNH Industrial is trading at $10.11, well below its 20‑day ($10.49), 50‑day ($10.65) and 200‑day ($10.80) moving averages, signaling a bearish technical backdrop. The RSI of 40.7 and a bearish MACD histogram reinforce short‑term downside pressure, while volume has been trending lower. On the fundamentals side, the forward PE of 13.9 contrasts sharply with a trailing PE of 31.6, suggesting the market may be undervaluing upcoming earnings growth. However, the balance sheet is a red flag: a debt‑to‑equity ratio above 300% and total debt of $26.3 bn dwarf the $1.35 bn cash pile, raising concerns about financial flexibility. Dividend sustainability is questionable given a 78% payout ratio on modest free cash flow and weak profit margins. Despite these challenges, the company posted flat Q1 revenue of $3.8 bn, received design award recognition, and analysts maintain a “Buy” consensus with a median price target of $12.25, indicating potential upside of roughly 20% from current levels. The sector’s cyclicality, high beta (1.15), and 30‑day volatility near 41% add to the risk profile, but the long‑term demand for agricultural and construction equipment remains a structural tailwind.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below all major moving averages
  • Bearish MACD and decreasing volume
  • High leverage and weak cash generation

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Forward earnings compression (PE 13.9)
  • Analyst buy consensus with price targets above current level
  • Cyclical exposure and ongoing debt reduction uncertainty

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Structural demand for farm and construction equipment
  • Potential upside from design awards and brand strength
  • Undervaluation relative to forward earnings and peer PE

Key Metrics & Analysis

Financial Health

Revenue Growth-0.10%
Profit Margin2.13%
P/E Ratio31.6
ROE4.84%
ROA0.95%
Debt/Equity333.72
P/B Ratio1.6
Op. Cash Flow$2.4B
Free Cash Flow$247.3M
Industry P/E29.7

Technical Analysis

TrendBearish
RSI40.7
Support$9.90
Resistance$11.03
MA 20$10.49
MA 50$10.65
MA 200$10.80
MACDBearish
VolumeDecreasing
Fear & Greed Index91.8

Valuation

Target Price$13.36
Upside/Downside32.13%
GradeUndervalued
TypeBlend
Dividend Yield0.99%

Risk Assessment

Beta1.15
Volatility40.69%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.